Beijing Kawin Technology Share-Holding Co., Ltd. (SHA:688687)
China · Delayed Price · Currency is CNY 35.71
+0.51 (1.45%)
Aug 1, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2017 - 2018 |
Chemical | 717.61M | Log In | Log In | Log In | Log In | Upgrade |
Chemical Growth | 92.66% | Log In | Log In | Log In | Log In | Upgrade |
Biologics | 670.88M | Log In | Log In | Log In | Log In | Upgrade |
Biologics Growth | -12.68% | Log In | Log In | Log In | Log In | Upgrade |
Contract Manufacture Organization/Contract Development and Manufacturing Organization | 16.39M | Log In | Log In | Log In | Log In | Upgrade |
Contract Manufacture Organization/Contract Development and Manufacturing Organization Growth | 45.91% | Log In | Log In | Log In | Log In | Upgrade |
Promotional Services | 4.58M | Log In | Log In | Log In | Log In | Upgrade |
Promotional Services Growth | 47.24% | Log In | Log In | Log In | Log In | Upgrade |
Technical Services | 1.05M | Log In | Log In | Log In | Log In | Upgrade |
Technical Services Growth | 143.09% | Log In | Log In | Log In | Log In | Upgrade |
Real Estate Leasing | 780.73K | Log In | Log In | Log In | Log In | Upgrade |
Real Estate Leasing Growth | -81.42% | Log In | Log In | Log In | Log In | Upgrade |
Other | 708.89K | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 226.64% | Log In | Log In | Log In | Log In | Upgrade |
Other Business | - | Log In | Log In | Log In | Log In | Upgrade |
Other Business Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Recombinant Human Interferon a2b | - | Log In | Log In | Log In | Log In | Upgrade |
Recombinant Human Interferon a2b Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Compound Glycyrrhizin Drugs | - | Log In | Log In | Log In | Log In | Upgrade |
Compound Glycyrrhizin Drugs Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2017 - 2018 |
China | 1.39B | Log In | Log In | Log In | Log In | Upgrade |
China Growth | 21.62% | Log In | Log In | Log In | Log In | Upgrade |
Overseas | 1.39M | Log In | Log In | Log In | Log In | Upgrade |
Overseas Growth | 418.04% | Log In | Log In | Log In | Log In | Upgrade |